By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Single segment31.74M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States139.74M100.00%
US Stock MarketDetailed Quotes
Beam Therapeutics (BEAM)
- 31.850
- +0.270+0.85%
Close May 13 16:00 ET
- 31.800
- -0.050-0.16%
Pre 07:49 ET
3.28BMarket Cap-65.00P/E (TTM)
32.530High31.000Low2.82MVolume31.000Open31.580Prev Close90.08MTurnover3.09%Turnover RatioLossP/E (Static)102.88MShares36.44052wk High2.81P/B2.91BFloat Cap15.35052wk Low--Dividend TTM91.39MShs Float138.522Historical High--Div Yield TTM4.85%Range %13.000Historical Low31.903Avg Price1Lot Size
Beam Therapeutics (BEAM) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm